Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.690
+0.120 (7.64%)
At close: Oct 8, 2025, 4:00 PM EDT
1.680
-0.010 (-0.59%)
After-hours: Oct 8, 2025, 6:20 PM EDT
Accuray Revenue
In the fiscal year ending June 30, 2025, Accuray had annual revenue of $458.51M with 2.68% growth. Accuray had revenue of $127.54M in the quarter ending June 30, 2025, a decrease of -5.02%.
Revenue (ttm)
$458.51M
Revenue Growth
+2.68%
P/S Ratio
0.38
Revenue / Employee
$463,136
Employees
990
Market Cap
190.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 458.51M | 11.95M | 2.68% |
Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ARAY News
- 12 hours ago - Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System - PRNewsWire
- 8 days ago - Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care - PRNewsWire
- 8 days ago - Accuray Incorporated (ARAY) Shareholder/Analyst Call Transcript - Seeking Alpha
- 12 days ago - Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care - PRNewsWire
- 27 days ago - Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025 - PRNewsWire
- 2 months ago - Accuray Incorporated (ARAY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results - PRNewsWire
- 2 months ago - Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025 - PRNewsWire